IN BRIEF—Moderna names James Mock as CFO

US messenger RNA (mRNA) therapeutics and vaccines company Moderna says that James Mock has been appointed as its new chief financial officer (CFO).

Prior to joining Moderna, Mr Mock served as senior vice president and CFO of PerkinElmer, where he was responsible for the strategy and operations of all finance functions. Before that, he served for nearly 20 years in a wide range of financial oversight capacities within General Electric, both in the USA and overseas.

Mr Mock will succeed David Meline, who will remain as a consultant to the company to assist with the transition.

"I am thrilled to welcome Jamey to Moderna's executive committee as our CFO. Moderna is at an exciting stage with a growing mRNA platform, including four Phase III trials occurring this year and upcoming proof-of-concept data in rare diseases and immuno-oncology, significant commercial momentum and a strong financial position," said Stéphane Bancel, chief executive of the firm.